Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5405_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Essentials of Pharmaceutical Analysis
- •Preface
- •Contents
- •About the Authors
- •1.3 Classical Methods for Pharmaceutical Analysis
- •1.3.1 Classical Methods for Pharmaceutical Analysis
- •1.3.1.1 Impurity Profiling
- •1.3.1.2 Content Uniformity
- •1.3.1.3 Dissolution Testing
- •1.3.1.4 Assay Analysis
- •1.3.1.5 Water Content Determination
- •1.3.1.6 Residual Solvent Analysis
- •1.3.1.7 Microbiological Analysis
- •1.3.1.8 Physical Characterization
- •1.3.1.9 Gravimetric Analysis
- •1.3.1.10 Titrimetric Analysis
- •1.3.1.11 Volumetric Analysis
- •1.3.1.12 Colorimetry
- •1.3.1.13 Spectroscopic Analysis
- •1.3.1.14 Chemical Spot Tests
- •1.3.1.15 Chromatographic Analysis
- •1.3.1.16 Polarimetry
- •1.3.2 Instrumental Methods for Pharmaceutical Analysis
- •1.3.2.1 Optical Methods for Pharmaceutical Analysis
- •1.3.2.1.1 Absorption of Radiation Methods for Pharmaceutical Analysis
- •1.3.2.1.1.1 UV-Visible Spectroscopy
- •1.3.2.1.1.2 Infrared Spectroscopy
- •1.3.2.1.1.3 Near-Infrared Spectroscopy
- •1.3.2.1.1.4 Raman Spectroscopy
- •1.3.2.1.1.5 X-Ray Absorption Spectroscopy
- •1.3.2.1.1.6 X-Ray Photoelectron Spectroscopy
- •1.3.2.1.1.7 Electron Paramagnetic Resonance Spectroscopy
- •1.3.2.1.1.8 Mössbauer Spectroscopy
- •1.3.2.1.2 Emission of Radiation Methods for Pharmaceutical Analysis
- •1.3.2.1.2.1 Atomic Emission Spectroscopy
- •1.3.2.1.2.2 Flame Emission Spectroscopy
- •1.3.2.1.2.3 Mass Spectrometry
- •1.3.2.1.2.4 Nuclear Magnetic Resonance Spectroscopy
- •1.3.2.1.2.5 Fluorescence Spectroscopy
- •1.3.2.1.2.6 Time-Resolved Fluorescence
- •1.3.2.1.2.7 Phosphorescence Spectroscopy
- •1.3.2.1.2.8 Chemiluminescence
- •1.3.2.1.2.9 Radioactive Emission Methods
- •1.3.2.1.2.10 Photoluminescence
- •1. Comprehensive Insights into Pharmaceutical Analysis
- •1.3.2.2 Chromatographic Methods for Pharmaceutical Analysis
- •1.3.2.2.1 High-Performance Liquid Chromatography
- •1.3.2.2.2 Gas Chromatography
- •1.1 Introduction
- •1.2 Types of Pharmaceutical Analysis
- •1.2.1 Qualitative Analysis
- •1.2.2 Quantitative Analysis
- •1.5.3 Regulatory Compliance
- •1.5.4 Research and Innovation
- •1.5.5 Quality Assurance and Product Quality
- •1.5.6 International Trade and Export
- •1.3.2.2.3 Liquid Chromatography-Mass Spectrometry
- •1.3.2.2.4 Gas Chromatography-Mass Spectrometry
- •1.3.2.2.5 Thin-Layer Chromatography
- •1.3.2.2.6 Supercritical Fluid Chromatography
- •1.3.2.2.7 Ion-Exchange Chromatography
- •1.3.2.2.8 Chiral Chromatography
- •1.3.2.2.9 Size-Exclusion Chromatography
- •1.3.3 Electrochemical Methods for Pharmaceutical Analysis
- •1.3.3.1 Potentiometry
- •1.3.3.2 Amperometry
- •1.3.3.3 Voltammetry
- •1.3.3.4 Polarography
- •1.3.3.5 Electrochemical Impedance Spectroscopy
- •1.3.3.6 Conductometry
- •1.3.3.7 Coulometry
- •1.3.3.8 Biosensors
- •1.3.4 Radiochemical Methods for Pharmaceutical Analysis
- •1.3.4.1 Radiolabeling
- •1.3.4.2 Radioimmunoassay
- •1.3.4.3 Positron Emission Tomography
- •1.3.4.4 Gamma Scintillation Spectrometry
- •1.3.4.5 Liquid Scintillation Counting
- •1.3.4.6 Autoradiography
- •1.3.4.7 Radiolabeled Drug Dissolution Studies
- •1.3.5 Thermal Methods for Pharmaceutical Analysis
- •1.3.5.1 Differential Scanning Calorimetry
- •1.3.5.2 Thermogravimetric Analysis
- •1.3.5.3 Differential Thermal Analysis
- •1.3.5.4 Accelerated Stability Testing
- •1.3.5.5 Thermomicroscopy
- •1.3.5.6 Dynamic Mechanical Analysis
- •1.4 Where We Do Pharmaceutical Analysis
- •1.4.1 Pharmaceutical Industry Laboratories
- •1.4.2 Contract Research Organizations
- •1.4.3 Regulatory Authorities
- •1.4.4 Academic and Research Institutions
- •1.4.5 Hospitals and Clinical Laboratories
- •1.4.6 Pharmacies and Compounding Facilities
- •1.4.7 Drug Testing and Control Laboratories
- •1.4.8 Forensic Laboratories
- •1.4.9 Clinical Trial Laboratories
- •1.4.10 Research and Development Centers
- •1.4.11 Quality Control and Quality Assurance Laboratories
- •1.4.12 Environmental and Toxicological Laboratories
- •1.5 Socioeconomic Impact of Pharmaceutical Analysis
- •1.5.1 Patient Safety and Health
- •1.5.2 Public Health and Disease Control
- •1.5.7 Intellectual Property and Market Competition
- •1.5.8 Drug Pricing and Access
- •1.5.9 Counterfeit Drug Detection
- •1.5.10 Employment and Workforce Development
- •1.5.11 Pharmaceutical Waste Reduction
- •1.5.12 Healthcare System Efficiency
- •1.6.1 Present Situation
- •1.6.2 Future Trends
- •1.7 Basic Requirements for Pharmaceutical Analysis
- •1.7.1 Regulatory Compliance
- •1.7.2 Analytical Method Validation
- •1.7.3 Instrument Calibration and Qualification
- •1.7.4 Sample Preparation
- •1.7.5 Data Integrity and Documentation
- •1.7.6 QC and QA
- •1.7.7 Stability Testing
- •1.7.8 Reference Standards
- •1.7.9 Method Transfer and Method Verification
- •1.7.10 Safety and Environmental Considerations
- •1.7.11 Audit and Inspection Readiness
- •1.7.12 Personnel Training and Qualification
- •1.7.13 Instrument and Method Performance Monitoring
- •1.7.14 Analytical Balances
- •1.7.15 pH Meters
- •1.7.16 Ovens and Incubators
- •1.7.17 Autoclaves
- •1.7.18 Microscopes
- •1.7.19 Centrifuge Machines
- •1.7.20 Filtration Apparatus
- •1.7.21 Magnetic Stirrers
- •1.7.22 Distillation Apparatus
- •1.7.23 Melting Point Apparatus
- •1.7.24 Evaporators
- •1.7.25 Autotitrators
- •1.7.26 Karl Fischer Titrators
- •1.7.27 Environmental Chambers
- •1.7.28 Sample Vials and Containers
- •1.7.29 Homogenizers
- •1.7.30 Ultrasonic Cleaners
- •1.7.31 Laboratory Glassware
- •1.7.32 Heating Mantles
- •1.7.33 Liquid Handling Equipment
- •1.8 Terminologies Used in Pharmaceutical Analysis
- •1.8.1 Active Pharmaceutical Ingredient
- •1.8.2 Analyte
- •1.8.3 Analytical Blank
- •1.8.4 Calibration
- •1.8.5 Standard Solution
- •1.8.6 Standard Solution
- •1.8.7 Molarity
- •1.8.8 Normality
- •1.8.9 Indicators
- •1.8.10 Batch Analysis
- •1.8.11 In Vitro Testing
- •1.8.12 In Vivo Testing
- •1.8.13 pH
- •1.8.14 Titration
- •1.8.15 Limit of Detection
- •1.8.16 Limit of Quantification
- •1.8.17 Linearity
- •1.8.18 Sensitivity
- •1.8.19 Precision
- •1.8.20 Accuracy
- •1.8.21 Selectivity
- •1.8.22 Matrix
- •1.8.23 Validation
- •1.8.24 Specificity
- •1.8.25 Reproducibility
- •1.8.26 Good Laboratory Practice
- •1.8.27 Repeatability
- •1.8.28 Dilution
- •1.8.29 Range
- •1.8.30 Pharmacopoeia
- •1.8.31 Robustness
- •1.8.32 Active Pharmaceutical Ingredient
- •1.8.33 Excipients
- •1.8.34 Contaminant
- •1.8.35 Assay
- •1.8.36 Impurity
- •1.8.37 Stability Testing
- •1.8.38 Bioavailability
- •1.8.39 Quality Control
- •1.8.40 Chromatography
- •1.8.41 Good Manufacturing Practices
- •1.8.42 Regulatory Compliance
- •1.8.43 Batch Release
- •1.8.44 Formulation
- •1.8.45 Dosage Form
- •1.8.46 Counterfeit Drugs
- •1.8.47 Range of method
- •1.9 Calibration of Analytical Method for Pharmaceutical Analysis
- •1.9.1 Select Suitable Standards
- •1.9.2 Instrument Calibration
- •1.9.3 Generate Calibration Curve
- •1.9.4 Evaluate Linearity
- •1.9.5 Calculate Regression Equation
- •1.9.6 Quality Control Samples
- •1.9.7 Method Validation
- •1.9.8 Use of Calibration Curve
- •1.9.9 Blank Correction
- •1.9.10 Record and Report Results
- •1.10 Statistical Analysis
- •1.10.1 Descriptive Statistics
- •1.10.2 Hypothesis Testing
- •1.10.3 Regression Analysis
- •1.10.4 Design of Experiments
- •1.10.5 Control Charts
- •1.10.6 Capability Analysis
- •1.10.7 Multivariate Analysis
- •1.10.8 Nonparametric Statistics
- •1.10.9 Reliability Analysis
- •1.10.10 Cluster Analysis
- •1.10.11 Time Series Analysis
- •1.10.12 Survival Analysis
- •1.10.13 Monte Carlo Simulation
- •1.10.14 Analysis of Variance
- •1.10.14.1 Null Hypothesis
- •1.10.14.2 Alternative Hypothesis
- •1.10.14.3 F-Statistic
- •1.10.14.4 Types of ANOVA
- •1.10.14.5 ANOVA Table
- •1.10.14.6 Interpretation
- •1.10.14.7 Applications of ANOVA in Pharmaceutical Analysis
- •1.11 Errors
- •1.11.1 Systematic Errors
- •1.11.2 Precision Errors
- •1.11.3 Sampling Errors
- •1.11.4 Interference and Contamination
- •1.11.5 Procedural Errors
- •1.11.6 Environmental Errors
- •1.11.7 Reference Material Errors
- •1.11.8 Indeterminate Errors
- •1.11.9 Sources of Errors
- •1.12 Emerging Trends in Pharmaceutical Analysis
- •1.12.1 Metabolomics in Drug Development
- •1.12.2 Proteomics for Studying Drug Effects
- •1.12.3 Microfluidic-Based Analysis
- •1.12.4 Nanotechnology Applications
- •1.12.5 Artificial Intelligence and Machine Learning
- •1.12.6 Green Analytical Chemistry
- •1.12.7 Real-Time and In-Process Monitoring
- •1.12.8 Advanced Chromatographic Techniques
- •1.12.9 Regulatory Trends
- •1.13 Applications of Pharmaceutical Analysis
- •1.13.1 Quality Control of Drug Products
- •1.13.2 Analysis of Active Pharmaceutical Ingredients
- •1.13.3 Impurity Profiling
- •1.13.4 Stability Testing
- •1.13.5 Bioequivalence Studies
- •1.13.6 Dissolution Testing
- •1.13.7 Assay Development
- •1.13.8 Pharmacopoeial Compliance
- •1.13.9 Pharmacokinetics and Pharmacodynamics Studies
- •1.13.10 Biopharmaceutical Analysis
- •1.13.11 Formulation Development
- •1.13.12 Validation of Analytical Methods
- •1.13.13 Environmental Monitoring
- •1.13.14 Forensic Analysis
- •1.13.15 Research and Development
- •1.14 Standard Operating Procedures in Pharmaceutical Analysis
- •1.14.1 Role of SOPs in Pharmaceutical Analysis
- •1.15 Conclusion
- •1.16 Short Questions
- •1.17 Multiple Choice Questions
- •Suggested Reading
- •2. Comprehensive Insights into Spectrophotometric Analysis
- •2.1 Introduction
- •2.2 Basic Principle
- •2.3 Absorbance and Emission
- •2.4 Quantitative and Qualitative Analysis
- •2.5 Understanding the Chemical Properties of Analyte
- •2.6 Photometry
- •2.7 Spectrophotometry
- •2.8 Spectrum
- •2.8.1 Electromagnetic Spectrum
- •2.8.2 Optical Spectrum
- •2.8.3 Spectral Lines
- •2.8.3.1 Emission Lines
- •2.8.3.2 Absorption Lines
- •2.8.3.3 Band Spectra
- •2.8.3.4 Continuous Spectrum
- •2.8.3.5 Fine Structure Spectral Lines
- •2.8.3.6 Hyperfine Structure Spectral Lines
- •2.8.3.7 Zeeman Effect Spectral Lines
- •2.8.3.8 Stark Effect Spectral Lines
- •2.8.4 Mass Spectrum
- •2.8.5 Energy Spectrum
- •2.8.6 Absorption Spectrum
- •2.8.7 Emission Spectrum
- •2.9 Electromagnetic Radiations
- •2.9.1 Frequency
- •2.9.2.1 Radio Waves
- •2.9.2.2 Microwaves
- •2.9.2.3 Infrared (IR) Radiation
- •2.9.2.4 Visible Light
- •2.9.2.5 Ultraviolet (UV) Radiation
- •2.9.2.6 X-Rays
- •2.9.2.7 Gamma Rays
- •2.9.3 Levels of Electromagnetic Radiations
- •2.9.3.1 Electronic Energy Levels
- •2.9.3.2 Vibrational Energy Levels
- •2.9.3.3 Rotational Energy Levels
- •2.10 Principle of Spectroscopy
- •2.11 Photometer
- •2.11.1 Absolute Photometers
- •2.11.2 Relative Photometers
- •2.11.3 Filter Photometers
- •2.11.4 Spectrophotometers
- •2.11.5 Colorimeters
- •2.11.6 Integrating Sphere Photometers
- •2.11.7 Luminosity Photometers
- •2.11.8 Radiometers
- •2.11.9 Photoelectric Photometers
- •2.11.10 Portable Photometers
- •2.12 Spectrophotometer
- •2.12.1 Components of Spectrophotometer
- •2.12.2 Types of Spectrophotometers
- •2.12.2.1 Single-Beam Spectrophotometer
- •2.12.2.2 Double-Beam Spectrophotometer
- •2.12.3 Types of Spectrophotometric Techniques
- •2.12.3.1 Absorption Spectroscopy
- •2.12.3.2 UV-Visible Spectroscopy
- •2.12.3.3 Infrared Spectroscopy
- •2.12.3.4 Nuclear Magnetic Resonance Spectroscopy
- •2.12.3.5 Atomic Absorption Spectroscopy
- •2.12.3.6 Fluorescence Spectroscopy
- •2.12.3.7 Emission Spectroscopy
- •2.12.3.8 Flame Emission Spectroscopy
- •2.12.3.9 Inductively Coupled Plasma Emission Spectroscopy
- •2.12.3.10 Chemiluminescence and Bioluminescence
- •2.12.3.11 Photoluminescence
- •2.12.3.12 Fluorescence Spectroscopy
- •2.12.3.13 Scattering Spectroscopy
- •2.12.3.14 Raman Spectroscopy
- •2.12.3.15 Dynamic Light Scattering
- •2.13 Fluorimeter
- •2.13.1 Filter-Based Fluorimeters
- •2.13.2 Spectrofluorometers
- •2.13.3 Time-Resolved Fluorimeters
- •2.13.4 Fluorescence Plate Readers
- •2.13.5 Portable Fluorimeters
- •2.14 Spectra
- •2.14.1 Types of Spectra
- •2.14.2 Rules for Interpretation of Spectra
- •2.14.3 Factors Affecting Spectra
- •2.15 Applications
- •2.16 Conclusion
- •2.17 Multiple Choice Questions
- •2.18 Short Questions
- •Suggested Reading
- •3. Comprehensive Insights into UV-VIS Spectrophotometry
- •3.1 Introduction
- •3.2 Principle
- •3.3 Theory
- •3.4 Electronic Transitions
- •3.4.1 Types of Electronic Transitions
- •3.5 Origin of Absorption Spectra
- •3.5.1 Electrons Present in Molecules
- •3.5.2 Rules for Interpretation of Absorption Spectra
- •3.5.3 Factors Affecting Absorption Spectra
- •3.5.3.1 Nature of the Molecule
- •3.5.3.2 Temperature
- •3.5.3.3 Concentration
- •3.5.3.4 pH
- •3.5.3.5 Solvent Polarity
- •3.5.3.6 Solvent Interactions
- •3.5.3.7 Nature of Electronic Transitions
- •3.6.2 Base Values for Different Classes of Compounds
- •3.6.3 Substituent Effects
- •3.6.4 Examples of Application
- •3.6.5 Limitations
- •3.7 Components of UV-VIS Spectrophotometer
- •3.7.1 Light Sources
- •3.7.2 Monochromator
- •3.7.2.1 Components of Monochromator
- •3.7.2.2 Working of Monochromator
- •3.7.3 Sample Device/Cuvette
- •3.7.4 Detector
- •3.7.4.1 Functions of Detector in Spectrophotometer
- •3.7.4.2 Types of Detectors
- •3.7.5 Wavelength Selector/Controller
- •3.7.6 Data Display/Recorder
- •3.7.7 Power Supply and Electronics
- •3.7.8 Control Panel
- •3.7.9 Computer Interface
- •3.8 Types of UV-VIS Spectrophotometer
- •3.8.1 Single-Beam UV-VIS Spectrophotometer
- •3.8.2 Double-Beam UV-VIS Spectrophotometer
- •3.8.3 Split-Beam UV-VIS Spectrophotometer
- •3.8.4 Scanning UV-VIS Spectrophotometer
- •3.8.6 Fixed-Wavelength UV-VIS Spectrophotometer
- •3.8.7 Microvolume UV-VIS Spectrophotometer
- •3.8.8 Nanodrop UV-VIS Spectrophotometer
- •3.9 Sample Preparation Techniques for UV-VIS Spectroscopy
- •3.9.1 Sample Stability
- •3.9.2 Dilution
- •3.9.3 Filtration
- •3.9.4 Extraction
- •3.9.5 Selection of Solvent
- •3.9.6 Dissolution
- •3.9.7 Cuvettes
- •3.9.8 Blank Solution
- •3.9.9 Homogenization
- •3.9.10 Handling Light-Sensitive Compounds
- •3.9.11 Sample Volume
- •3.9.12 Background Correction
- •3.9.13 Solid Sample Analysis
- •3.9.14 Calibration Standards
- •3.9.15 Temperature Control
- •3.9.16 Sample Stability
- •3.9.17 Record Sample Information
- •3.10 Absorbance Laws
- •3.10.1.1 Beer Derivation
- •3.10.3.1 HOMO and LUMO Conceptual Integration
- •3.10.3.3.1 Real Deviations
- •3.10.3.3.2 Chemical Deviations
- •3.10.3.3.3 Instrumental Deviations
- •3.10.3.3.4 Due to Polychromatic Radiation
- •3.10.3.3.5 Due to the Presence of Scattered Radiation
- •3.11 Instrument Calibration in UV-VIS Spectroscopy
- •3.11.1 Key Aspects of Instrument Calibration
- •3.11.2 Calibration Procedure
- •3.12 Terms Used in UV-VIS Spectroscopy
- •3.12.1 Chromophore
- •3.12.2 Auxochrome
- •3.12.3 Absorption and Intensity Shifts in UV-VIS Spectroscopy
- •3.12.3.1 Bathochromic Shift (Red Shift)
- •3.12.3.2 Hypsochromic Shift (Blue Shift)
- •3.12.3.3 Hyperchromic Shift
- •3.12.3.4 Hypochromic Shift
- •3.13 Factors Affecting UV-VIS Spectroscopy Results
- •3.13.1 Concentration of the Analyte
- •3.13.2 Path Length of the Cuvette
- •3.13.3 Wavelength Selection
- •3.13.4 Instrumental Factors
- •3.13.5 Solvent Effects
- •3.13.6 Sample Contaminants
- •3.13.7 Temperature
- •3.13.8 Sample Stability
- •3.14 Data Analysis and Interpretation
- •3.14.1 Plotting Absorption Spectra
- •3.14.2 Determining Concentration
- •3.14.3 Identifying Unknown Compounds
- •3.15 Limitations and Challenges
- •3.15.1 Sensitivity
- •3.15.2 Overlapping Absorption Bands
- •3.15.3 Instrumental Noise
- •3.15.4 Sample Contamination
- •3.16 Recent Advancements in UV-VIS Spectroscopy
- •3.16.1 Miniaturized Spectrophotometers
- •3.16.2 Fiber-Optic UV-VIS Spectroscopy
- •3.16.3 Computational Methods in Spectral Analysis
- •3.17 Future Trends and Developments
- •3.17.1 Integration with Other Analytical Techniques
- •3.17.2 Advances in Data Processing and Automation
- •3.18 Applications
- •3.18.1 Determination of Molecular Weight
- •3.18.2 Detection of Impurities
- •3.18.3 Quantitative Analysis
- •3.18.4 Qualitative Analysis of Pharmaceuticals
- •3.18.5 Detection of Functional Group
- •3.18.6 Chemical Kinetics
- •3.18.7 Determination of Unknown Concentration
- •3.18.8 Structural Elucidation of Organic Compounds
- •3.18.9 As HPLC Detector
- •3.19 Conclusion
- •3.20 Multiple Choice Questions
- •3.21 Short Questions
- •Suggested Reading
- •4. Comprehensive Insights into Infrared Spectroscopy
- •4.1 Introduction
- •4.2 Regions of IR
- •4.3 Principle
- •4.4 Modes of Molecular Vibrations
- •4.4.1 Stretching Vibration
- •4.4.1.1 Symmetrical Stretching Vibration
- •4.4.1.2 Asymmetrical Stretching Vibration
- •4.4.2 Bending Vibrations
- •4.4.2.1 In-Plane Bending Vibrations
- •4.4.2.1.1 Scissoring Vibration
- •4.4.2.2 Out-Plane Bending Vibrations
- •4.4.2.2.1 Wagging Vibration
- •4.4.2.2.2 Twisting Vibration
- •4.5 Reference Guide for IR Spectra of Functional Groups
- •4.6 Characteristic Peaks for Amines
- •4.7 Differentiating Between Amide I, Amide II, and Amide III Bands
- •4.8 Components of IR Spectrophotometer
- •4.8.1 Sample Cell
- •4.8.2 Monochromator
- •4.9 Sampling Techniques for IR Spectroscopy
- •4.9.1 Solid Samples
- •4.9.1.1 Mulling
- •4.9.1.2 Pelleting
- •4.9.1.3 Thin Film Formation
- •4.9.2 Liquid Samples
- •4.9.3 Gas Samples
- •4.10 Types of IR Spectroscopy
- •4.10.1 Dispersive IR Spectroscopy
- •4.10.2 FT-IR Spectroscopy
- •4.10.3 Near-IR Spectroscopy
- •4.11 Regions of IR Spectrum
- •4.12 Calculation of Vibrational Frequencies
- •4.13 Factors Affecting Vibrational Frequency
- •4.14 Interpretations of IR Spectrum
- •4.14.1 IR Spectra of Alkanes
- •4.14.2 IR Spectra of Alkenes
- •4.14.3 IR Spectra of Alkynes
- •4.14.4 IR Spectra of Aromatic Compounds
- •4.14.5 IR Spectra of Ethers
- •4.15 Factors Affecting the Interpretation of IR Spectra
- •4.16 Specialized IR Techniques
- •4.17 Instrumentation Advancements in IR Spectroscopy
- •4.18 Future Trends in IR Spectroscopy
- •4.19 Applications of IR Spectroscopy
- •4.19.1 Chemical Analysis
- •4.19.2 Pharmaceuticals
- •4.19.3 Structural Analysis
- •4.19.4 Protein Characterization
- •4.19.5 Drug Discovery
- •4.19.6 Research and Development
- •4.19.7 Quality Control
- •4.19.8 Comparative Analysis
- •4.19.9 Stability Studies
- •4.19.10 Formulation Development
- •4.19.11 Regulatory Compliance
- •4.19.12 Bioequivalence Assessment
- •4.19.13 Identification of Functional Groups
- •4.19.14 Quality Control and Consistency
- •4.19.15 Analysis of Polymer Blends and Copolymers
- •4.19.16 Detection of Polymer Degradation
- •4.19.17 Crosslinking and Curing
- •4.19.18 Characterization of Polymer Additives
- •4.19.19 Polymer Crystallinity
- •4.19.20 Monitoring Reactions in Polymer Synthesis
- •4.19.21 Intermediate Identification
- •4.19.22 Reaction Mechanism Investigation
- •4.19.23 Catalyst Studies
- •4.19.24 Quantitative Analysis
- •4.19.25 Materials Chemistry
- •4.19.26 Biochemical Reactions
- •4.19.27 Compatibility Studies
- •4.19.28 Characterization of Interactions
- •4.19.29 Identifying Excipient Effects
- •4.19.30 Structural Isomers
- •4.19.31 Positional Isomers
- •4.19.32 Inorganic Complexes
- •4.19.33 Medical Diagnosis
- •4.19.34 Chemical Synthesis
- •4.19.35 Quantitative Analysis
- •4.19.36 Environmental Analysis
- •4.19.37 Materials Science
- •4.19.38 Food and Beverage Industry
- •4.19.39 Forensic Science
- •4.19.40 Agriculture
- •4.19.41 Art and Cultural Heritage
- •4.19.42 Petrochemical Industry
- •4.19.43 Cosmetics
- •4.19.44 Geology and Mineralogy
- •4.20 Conclusion
- •4.21 Multiple Choice Questions
- •4.22 Short Questions
- •Suggested Reading
- •5. Comprehensive Insights into Atomic Spectroscopy
- •5.1 Introduction
- •5.2 Principle
- •5.2.1 Energy Levels and Transitions
- •5.2.2 Ground State and Excited State
- •5.2.3 Wavelengths and Spectral Lines
- •5.2.4 Doppler Broadening
- •5.3 Types of Atomic Spectroscopy
- •5.3.1 Atomic Absorption Spectrometry (AAS)
- •5.3.2 Atomic Emission Spectrometry (AES)
- •5.3.3 Atomic Fluorescence Spectrometry (AFS)
- •5.3.5 Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
- •5.3.6 X-Ray Fluorescence Spectrometry (XRF)
- •5.3.7 Laser-Induced Breakdown Spectroscopy (LIBS)
- •5.4 Atomizers Used in Atomic Spectroscopy
- •5.4.1 Flame Atomizer
- •5.4.2 Electrothermal (Graphite Furnace) Atomizer
- •5.4.3 ICP Atomizer
- •5.4.4 Hydride Generation Atomizer
- •5.4.5 Cold Vapor Atomizer
- •5.4.6 Laser Ablation Atomizer
- •5.4.7 Glow Discharge Atomizer
- •5.5.1 Sample Digestion
- •5.5.2 Sample Nebulization
- •5.5.3 Sample Introduction Systems
- •5.6 Data Analysis and Interpretation in Atomic Spectroscopy
- •5.6.1 Calibration and Standardization
- •5.6.2 Quantification Methods
- •5.6.3 Qualitative Analysis
- •5.6.4 Sensitivity and Detection Limits
- •5.7 Impact of Temperature on Atomic Spectra
- •5.7.1 Doppler Broadening and Temperature
- •5.7.2 Boltzmann Distribution and Energy Level Population
- •5.7.3 Ionization Effects
- •5.8 Impact of Pressure Broadening on Atomic Spectra
- •5.8.1 How Pressure Broadening Works
- •5.8.2 Factors in Pressure Broadening
- •5.8.3 Impact of Pressure Broadening on Spectral Lines
- •5.8.4 Applications
- •5.9 Factors Affecting Sensitivity
- •5.9.1 Instrument Parameters
- •5.9.2 Analyte Properties
- •5.9.3 Sample Preparation
- •5.9.4 Spectral Interferences
- •5.9.5 Signal-to-Noise Ratio
- •5.10 Sample Matrix Effects and Interferences
- •5.10.1 Chemical Interferences
- •5.10.2 Ionization and Atomization Interferences
- •5.10.3 Chemical Reactions
- •5.10.4 Matrix Components
- •5.10.5 Spectral Interferences
- •5.10.6 Line Overlap
- •5.10.7 Isotopic Interferences
- •5.10.8 Continuum Interferences
- •5.11 Strategies for Minimizing Interferences
- •5.11.1 Internal Standards
- •5.11.2 Chemical Modifiers
- •5.11.3 Background Correction
- •5.11.4 Spectral Resolution
- •5.11.5 Standard Addition
- •5.11.6 Isotope Dilution
- •5.12 Quality Assurance and Quality Control
- •5.12.1 Calibration Checks
- •5.12.2 Calibration Verification
- •5.12.3 Linearity Checks
- •5.12.4 Response Drift
- •5.12.5 Internal Standards
- •5.12.6 Stability
- •5.12.7 Known Concentration
- •5.12.8 Correction for Variability
- •5.12.9 Proficiency Testing
- •5.12.10 Blind Samples
- •5.12.11 Method Validation
- •5.12.12 Participation in Proficiency Programs
- •5.12.13 Corrective Actions
- •5.13 Recent Advances and Emerging Technologies
- •5.13.1 Nanomaterials in Atomic Spectroscopy
- •5.13.2 Miniaturized and Portable Atomic Spectrometers
- •5.13.3 Hyphenated Techniques
- •5.14 Future Trends in Atomic Spectroscopy
- •5.14.1 Advanced Data Analysis
- •5.14.2 Nanotechnology
- •5.14.3 Environmental and Biological Applications
- •5.14.4 3D Printing
- •5.14.5 Automation and Robotics
- •5.14.6 Emerging Spectroscopic Techniques
- •5.14.7 Remote Sensing
- •5.15 Applications
- •5.15.1 Drug Purity and Quality Control
- •5.15.2 Pharmacokinetics and Bioavailability
- •5.15.3 Stability Studies
- •5.15.4 Dissolution Testing
- •5.15.5 Pharmaceutical Impurities
- •5.15.6 Counterfeit Drug Detection
- •5.15.7 Quality Assurance and Regulatory Compliance
- •5.15.8 Biopharmaceuticals
- •5.15.9 Excipient Analysis
- •5.15.10 Process Validation and Verification
- •5.15.11 Formulation Development
- •5.15.12 Method Development and Validation
- •5.15.13 Clinical Trials
- •5.15.14 Research and Development
- •5.15.15 Metabolomics and Proteomics
- •5.15.16 Environmental Monitoring
- •5.15.17 Geochemical Studies
- •5.15.18 Metallurgy
- •5.15.19 Nanomaterials
- •5.15.20 Clinical Chemistry
- •5.15.21 Biological and Medical Research
- •5.15.22 Soil Analysis
- •5.15.23 Food Safety
- •5.15.24 Archeological and Cultural Heritage Studies
- •5.15.25 Environmental Toxicology
- •5.15.26 Remote Sensing and Space Exploration
- •5.15.27 Petroleum and Petrochemical Industries
- •5.15.28 Art and Conservation
- •5.15.29 Mining and Exploration
- •5.15.30 Nuclear Industry
- •5.16 Conclusion
- •5.17 Multiple Choice Questions
- •5.18 Short Questions
- •Suggested Reading
- •6. Comprehensive Insights into Atomic Absorption Spectroscopy
- •6.1 Introduction
- •6.2 Principle
- •6.3 Components of AAS
- •6.3.1 Radiation Source
- •6.3.2 Chopper
- •6.3.3 Atomizers
- •6.3.3.1 Flame Atomizers
- •6.3.3.2 Premixed Burner
- •6.3.4 Nebulization
- •6.3.5 Monochromators
- •6.3.6 Detectors
- •6.3.7 Amplifier
- •6.3.8 Readout Device
- •6.4 Working of AAS
- •6.5 Types of AAS
- •6.5.1 Single Beam AAS
- •6.5.2 Double Beam AAS
- •6.5.3 Flame Atomic Absorption Spectroscopy (FAAS)
- •6.5.4 Graphite Furnace Atomic Absorption Spectroscopy (GF-AAS)
- •6.5.6 Cold Vapor Atomic Absorption Spectroscopy (CV-AAS)
- •6.6.1 Sample Preparation
- •6.6.2 Calibration
- •6.6.3 Measurement Setup
- •6.6.4 Sample Analysis
- •6.6.5 Comparison to Blank
- •6.6.6 Data Recording
- •6.6.7 Concentration Determination
- •6.6.8 Data Presentation
- •6.7 Analysis of Data Generated by AAS
- •6.7.1 Calibration
- •6.7.2 Sample Analysis
- •6.7.3 Data Interpretation
- •6.7.4 Concentration Calculation
- •6.7.5 Quality Control
- •6.7.6 Statistical Analysis
- •6.7.7 Reporting
- •6.7.8 Validation
- •6.7.9 Interference Correction
- •6.8.1 FAAS
- •6.8.2 GFAAS
- •6.8.3 HG-AAS
- •6.8.4 CVAAS
- •6.8.5 HR-CS AAS
- •6.8.6 TDL-AAS
- •6.9 Methods for Quantitative Analysis in AAS
- •6.9.1 Calibration Curve Method
- •6.9.2 Standard Addition Technique
- •6.9.3 Choosing Between the Two Methods
- •6.10 Interferences of AAS
- •6.10.1 Ionization Interference
- •6.10.2 Background Absorption of Source Radiation Interference
- •6.10.3 Transport of Sample Interferences
- •6.10.6 Oxide Formation Interference
- •6.10.7 Spectral Interferences
- •6.10.8 Chemical Interferences
- •6.10.9 Physical Interferences
- •6.10.10 Vaporization Interferences
- •6.11 Strategies for Overcoming and Controlling Interferences in AAS
- •6.11.1 Ionization Suppression
- •6.11.2 Flame Reactions
- •6.11.3 Use of Chemical Modifiers
- •6.11.4 Matrix Matching
- •6.11.5 Background Correction
- •6.11.5.1 Smith-Hieftje Method
- •6.11.5.2 Zeeman Effect Background Correction
- •6.11.6 Wavelength Selection
- •6.11.7 Sample Dilution
- •6.11.8 Temperature and Atomization Control
- •6.11.9 Use of Standard Addition
- •6.11.10 Routine Calibration
- •6.11.11 Reference Standards
- •6.11.12 Method Validation
- •6.11.13 Instrument Maintenance
- •6.12 Sample Preparation for AAS
- •6.12.1 Sample Collection
- •6.12.2 Sample Digestion
- •6.12.3 Dilution
- •6.12.4 Filtration
- •6.12.5 Homogenization
- •6.12.6 Standard Solutions
- •6.12.7 Matrix-Matching
- •6.13 Applications
- •6.13.1 Drug Purity Analysis
- •6.13.2 Quality Control
- •6.13.3 Elemental Impurity Testing
- •6.13.4 Biological Sample Analysis
- •6.13.5 Pharmacokinetics Studies
- •6.13.6 Dissolution Testing
- •6.13.7 Environmental Analysis
- •6.13.8 Geological Exploration
- •6.13.9 Food and Beverage Analysis
- •6.13.10 Toxicology Studies
- •6.13.11 Nutritional Studies
- •6.13.12 Monitoring Trace Elements
- •6.13.13 Pharmacokinetics Research
- •6.13.14 Hematology and Hemoglobin Analysis
- •6.13.15 Environmental Exposure Assessment
- •6.13.16 Toxicity Studies
- •6.13.17 Biological Specimen Analysis
- •6.13.18 Pharmacological Studies
- •6.13.19 Microbiological Research
- •6.13.20 Proteomics and Metalloproteins
- •6.13.21 Neurological Research
- •6.13.22 Genetic and Genomic Studies
- •6.13.23 Agricultural Applications
- •6.13.24 Material Science
- •6.13.25 Forensic Analysis
- •6.13.26 Oil and Petrochemical Analysis
- •6.13.27 Water Quality Assessment
- •6.14 Precautionary Measures
- •6.14.1 Proper Training
- •6.14.2 Protective Gear
- •6.14.3 Ventilation
- •6.14.4 Chemical Compatibility
- •6.14.5 Sample Containment
- •6.14.6 Waste Disposal
- •6.14.7 Flame Safety
- •6.14.8 Gas Cylinder Handling
- •6.14.9 Instrument Maintenance
- •6.14.10 Emergency Equipment
- •6.14.11 Safety Procedures
- •6.14.12 Data Records
- •6.14.13 Contamination Prevention
- •6.14.14 Monitoring
- •6.14.15 Safety Data Sheets
- •6.14.16 Electrical Safety
- •6.14.17 Emergency Response
- •6.14.18 Proper Waste Labeling
- •6.14.19 Prohibited Activities
- •6.15 Conclusion
- •6.16 Multiple Choice Questions
- •6.17 Short Questions
- •Suggested Reading
- •7. Comprehensive Insights into Atomic Emission Spectroscopy
- •7.1 Introduction
- •7.2 Principle
- •7.3 Types of Emission Spectra Used in AES
- •7.3.1 Line Spectra
- •7.3.1.1 Formation of Line Spectra
- •7.3.1.2 Unique Spectral Fingerprint of Each Element
- •7.3.1.3 Importance for Elemental Identification
- •7.3.1.4 Correlation with Element Concentration
- •7.3.1.5 Observing Line Spectra in Practice
- •7.3.2 Band Spectra
- •7.3.2.1 Formation of Band Spectra
- •7.3.2.2 Common Observations in Molecular Species
- •7.3.2.3 Application in Molecular and Compound Analysis
- •7.3.2.4 Limitations for Quantitative Elemental Analysis
- •7.3.3 Continuous Spectra
- •7.3.3.1 Formation of Continuous Spectra
- •7.3.3.2 Common Sources of Continuous Spectra
- •7.3.3.3 Role in AES
- •7.3.3.4 Limitations in Elemental Analysis
- •7.3.4 Combination Spectra
- •7.3.4.1 Mixed Emission Sources
- •7.3.4.2 Interpreting Complex Emission Spectra
- •7.3.4.3 Significance in Analytical Applications
- •7.4 Components of AES
- •7.4.1 Emission Source
- •7.4.1.1 Flames
- •7.4.1.2 Plasmas
- •7.4.2 Monochromator
- •7.4.3 Detector
- •7.4.3.1 Common Types of Detectors in AES
- •7.4.3.2 Importance in AES
- •7.4.4 Readout Device
- •7.5 Role of Energy Transitions in Emission
- •7.5.1 Energy Levels in Atoms
- •7.5.2 Excitation Process
- •7.5.3 Emission of Light
- •7.5.4 Spectral Lines and Quantification
- •7.6 Working of AES
- •7.6.1 Sample Introduction
- •7.6.2 Atomization
- •7.6.2.1 Process Overview
- •7.6.2.2 Importance of Atomization
- •7.6.3 Excitation
- •7.6.4 Emission of Light
- •7.6.4.1 Characteristics of Emitted Light
- •7.6.4.2 Importance in Elemental Analysis
- •7.6.5 Wavelength Selection
- •7.6.6 Detection
- •7.6.6.1 Measurement of Intensity
- •7.6.6.2 Importance in AES
- •7.6.7 Data Analysis
- •7.7 Comparison Between AAS and AES
- •7.8 Interferences of AES
- •7.8.1 Spectral Interferences
- •7.8.2 Chemical Interferences
- •7.8.3 Physical Interferences
- •7.8.4 Memory Effects
- •7.8.4.1 Carryover Contamination
- •7.8.4.2 Influence on Calibration
- •7.8.4.3 Variability in Results
- •7.8.4.4 Mitigation Strategies
- •7.8.5 Background Emission
- •7.8.5.1 Source of Background Emission
- •7.8.5.2 Impact on Signal Detection
- •7.8.5.3 Fluctuations in Background Signal
- •7.8.5.4 Mitigation Strategies
- •7.8.6 Interference by Molecular Emission
- •7.8.6.1 Source of Molecular Emission
- •7.8.6.2 Overlap of Emission Lines
- •7.8.6.3 Complex Mixtures
- •7.8.6.4 Mitigation Strategies
- •7.9 Strategies for Overcoming and Controlling Interferences in AES
- •7.9.1 Wavelength Selection
- •7.9.2 Internal Standards
- •7.9.3 Spectral Deconvolution
- •7.9.4 Matrix Matching
- •7.9.5 Chemical Modifiers
- •7.9.6 Chemical Separation
- •7.9.7 Optimize Instrument Conditions
- •7.9.8 Background Correction
- •7.9.9 Sample Dilution
- •7.9.10 Rinsing and Cleaning
- •7.9.11 Data Quality Control
- •7.9.12 Blank Corrections
- •7.9.13 Calibration Standards
- •7.9.14 Standard Addition Method
- •7.9.15 Selective Spectroscopy
- •7.10 Types of Atomic Emission Spectroscopy
- •7.10.1 Flame Emission Spectroscopy (FES)
- •7.10.1.1 Principle
- •7.10.1.2 Key Components
- •7.10.1.3 Applications
- •7.10.2 ICP-AES
- •7.10.2.1 Principle
- •7.10.2.2 Key Components
- •7.10.2.3 Applications
- •7.10.3 Spark Emission Spectroscopy
- •7.10.4 Arc Emission Spectroscopy
- •7.10.5 Laser-Induced Breakdown Spectroscopy (LIBS)
- •7.10.6 Glow Discharge Emission Spectroscopy (GD-ES)
- •7.10.9 Optical Emission Spectroscopy (OES)
- •7.11 Recent Advancements in AES
- •7.11.1 Miniaturization and Portable AES Devices
- •7.11.2 Hyphenation Techniques
- •7.11.3 Improved Calibration Methods
- •7.11.4 Emerging Detection Technologies
- •7.11.5 Automation and High-Throughput Analysis
- •7.11.6 Nanomaterial Applications
- •7.12 Applications of AES
- •7.12.1 Drug Purity and Quality Control
- •7.12.2 Trace Metal Analysis
- •7.12.3 Pharmacokinetics
- •7.12.4 Analysis of Biological Fluids
- •7.12.5 Pharmacology and Toxicology
- •7.12.6 Clinical Diagnostics
- •7.12.7 Biological Tissue Analysis
- •7.12.8 Environmental Exposure Assessment
- •7.12.9 Nutritional Research
- •7.12.10 Research on Biological Processes
- •7.12.11 Metallomics
- •7.12.12 Biomedical Imaging
- •7.12.13 Dental Research
- •7.12.14 Environmental Monitoring
- •7.12.15 Food and Beverage Industry
- •7.12.16 Waste Management and Recycling
- •7.12.17 Forensic Science
- •7.12.18 Metallurgy and Materials Science
- •7.12.19 Geological Exploration
- •7.12.20 Agriculture
- •7.12.21 Art and Archaeology Conservation
- •7.12.22 Conclusion
- •7.13 Multiple Choice Questions
- •7.14 Short Questions
- •Suggested Reading
- •8. Comprehensive Insights into Molecular Emission Spectroscopy
- •8.1 Introduction
- •8.2 Electronic Spectra
- •8.2.1 Basic Principles of Electronic Spectra
- •8.2.2 Excitation Techniques in Electronic Spectroscopy
- •8.2.3 Spectral Analysis
- •8.3 Types of Luminescence
- •8.3.1 Fluorescence
- •8.3.2 Phosphorescence
- •8.3.3 Electroluminescence
- •8.3.4 Radioluminescence
- •8.4 Types of Molecular Emission Spectroscopy
- •8.4.1 Fluorescence Spectroscopy
- •8.4.2 Phosphorescence Spectroscopy
- •8.4.3 Photoluminescence Spectroscopy
- •8.4.4 Raman Spectroscopy
- •8.4.5 Laser-Induced Breakdown Spectroscopy (LIBS)
- •8.4.6 Cathodoluminescence Spectroscopy
- •8.4.7 Plasma Emission Spectroscopy
- •8.4.8 Chemiluminescence Spectroscopy
- •8.4.9 Bioluminescence Spectroscopy
- •8.5 Theory
- •8.5.1 Vibrational Relaxation
- •8.5.2 Internal Conversion
- •8.5.3 Photon Emission
- •8.5.4 Energy Transfer
- •8.8.9 Types of Spectrometers Used in MES
- •8.8.10 Functionalities of Spectrometers in MES
- •8.8.11 Computer and Software
- •8.8.12 Accessories
- •8.8.13 Optical Filters
- •8.8.13.1 Types of Optical Filters
- •8.6 Principle
- •8.7 Types of Fluorescence
- •8.8 Components of MES
- •8.8.1 Light Source
- •8.8.2 Sample Compartment
- •8.8.3 Monochromator
- •8.8.4 Sample Excitation and Emission Pathways
- •8.8.5 Detector
- •8.8.5.1 Photomultiplier Tubes (PMTs)
- •8.8.5.2 Charge-Coupled Device (CCD) Cameras
- •8.8.5.3 Avalanche Photodiodes (APDs)
- •8.8.5.4 Silicon Photodiodes
- •8.8.5.5 Photon Counting Modules (PCMs)
- •8.8.5.6 Microchannel Plate (MCP) Detectors
- •8.8.6 Data Acquisition System
- •8.8.7 Spectrometer
- •8.8.8 Components of a Spectrometer
- •8.8.13.2 Functions of Optical Filters
- •8.8.13.3 Applications of Optical Filters in MES
- •8.9 Types of Molecular Emission Spectra
- •8.9.1 Fluorescence Spectra
- •8.9.2 Phosphorescence Spectra
- •8.9.3 Chemiluminescence Spectra
- •8.9.4 Bioluminescence Spectra
- •8.10 Interpretation of Molecular Emission Spectra
- •8.10.1 Wavelength Analysis
- •8.10.2 Peak Intensity
- •8.10.3 Stokes Shift
- •8.10.4 Broadening of Peaks
- •8.10.5 Vibrational Structure
- •8.11 Factors Affecting Molecular Emission Spectra
- •8.11.1 Molecular Structure
- •8.11.2 Solvent Effects
- •8.11.3 Temperature
- •8.11.4 Concentration
- •8.11.5 pH and Ionic Strength
- •8.11.6 Electronic Coupling and Interactions
- •8.11.7 External Fields
- •8.12 Advancements in the Instrumentation of MES
- •8.12.1 Miniaturization and Portability
- •8.12.2 High-Resolution Spectrometers
- •8.12.3 Multimodal Imaging
- •8.12.4 Automated Data Analysis
- •8.12.5 Time-Resolved MES
- •8.12.6 Enhanced Sensitivity
- •8.12.7 Multichannel Detection
- •8.12.8 Adaptive Sampling and Microfluidics
- •8.12.9 High-Throughput Screening
- •8.12.10 Hyphenation with Other Techniques
- •8.13 Factors Influencing Fluorescence Intensity in MES
- •8.13.1 Excitation Wavelength
- •8.13.2 Fluorophore Concentration
- •8.13.3 Quantum Yield
- •8.13.4 Stokes Shift
- •8.13.5 Solvent Effects
- •8.13.6 pH
- •8.13.7 Temperature
- •8.13.8 Photobleaching
- •8.13.9 Environmental Factors
- •8.13.10 Oxygen Concentration
- •8.13.11 Inner Filter Effect
- •8.13.12 Self-quenching
- •8.13.13 Aggregation
- •8.13.14 Instrumental Factors
- •8.14 Applications
- •8.14.1 Drug Development
- •8.14.2 Drug Formulation
- •8.14.3 Pharmacokinetics and Pharmacodynamics
- •8.14.4 Quality Control
- •8.14.5 Protein Characterization
- •8.14.6 Cellular Imaging
- •8.14.7 Cancer Research
- •8.14.8 Molecular Genetics
- •8.14.9 Neuroscience
- •8.14.10 Flow Cytometry
- •8.14.11 Quantum Dots
- •8.14.12 Nanoparticles
- •8.14.13 Polymers and Composites
- •8.14.14 Monitoring Water Quality
- •8.14.15 Soil and Plant Analysis
- •8.14.16 Air Pollution Studies
- •8.14.17 Quality Assurance in Manufacturing
- •8.14.18 Process Control
- •8.14.19 Inspection and Testing
- •8.14.20 Crime Scene Analysis
- •8.14.21 Drug Testing
- •8.14.22 Document Authentication
- •8.15 Conclusion
- •8.16 Multiple Choice Questions
- •8.17 Short Questions
- •Suggested Reading
- •9. Comprehensive Insights into Mass Spectrometry
- •9.1 Introduction
- •9.2 Principle
- •9.3 Instrumentation
- •9.3.1 Inlet System
- •9.3.2 Ionization Source
- •9.3.2.1 Electron Ionization (EI)
- •9.3.2.1.1 Key Features of EI
- •9.3.2.1.2 Applications
- •9.3.2.2 Electrospray Ionization (ESI)
- •9.3.2.2.1 Key Features of ESI
- •9.3.2.2.2 Mechanism
- •9.3.2.2.3 Applications
- •9.3.2.2.4 Advantages
- •9.3.2.3 Chemical Ionization (CI)
- •9.3.2.3.1 Key Features of CI
- •9.3.2.3.2 Mechanism
- •9.3.2.3.3 Types of Reagent Gases
- •9.3.2.3.4 Ionization Process
- •9.3.2.3.5 Applications
- •9.3.2.3.6 Advantages
- •9.3.2.3.7 Limitations
- •9.3.2.4 Atmospheric Pressure Ionization (API)
- •9.3.2.4.1 Key Features of API
- •9.3.2.4.2 Types of API
- •9.3.2.4.3 General API Process
- •9.3.2.4.4 Applications of API
- •9.3.2.4.5 Advantages of API
- •9.3.2.4.6 Limitations
- •9.3.2.5 Fast Atom Bombardment (FAB)
- •9.3.2.5.1 Principle of FAB
- •9.3.2.5.2 Key Features of FAB
- •9.3.2.5.3 Process of FAB
- •9.3.2.5.4 Advantages of FAB
- •9.3.2.5.5 Limitations of FAB
- •9.3.2.5.6 Applications of FAB
- •9.3.2.6.1.1 Principle of ECD
- •9.3.2.6.1.2 Key Features of ECD
- •9.3.2.6.1.3 Advantages of ECD
- •9.3.2.6.1.4 Applications of ECD
- •9.3.2.6.2.1 Principle of ETD
- •9.3.2.6.2.2 Key Features of ETD
- •9.3.2.6.2.3 Advantages of ETD
- •9.3.2.6.2.4 Applications of ETD
- •9.3.2.7 Field Ionization (FI)
- •9.3.2.7.1 Principle of FI
- •9.3.2.7.2 Key Features of FI
- •9.3.2.7.3 Advantages of FI
- •9.3.2.7.4 Disadvantages of FI
- •9.3.2.7.5 Applications of FI
- •9.3.2.8 Desorption Electrospray Ionization (DESI)
- •9.3.2.8.1 Principle of DESI
- •9.3.2.8.2 Key Features of DESI
- •9.3.2.8.3 Advantages of DESI
- •9.3.2.8.4 Disadvantages of DESI
- •9.3.2.8.5 Applications of DESI
- •9.3.2.9 Atmospheric Pressure Photoionization (APPI)
- •9.3.2.9.1 Principle of APPI
- •9.3.2.9.2 Key Features of APPI
- •9.3.2.9.3 Advantages of APPI
- •9.3.2.9.4 Disadvantages of APPI
- •9.3.2.9.5 Applications of APPI
- •9.3.2.9.6 Comparison of ESI, APCI, and APPI
- •9.3.2.10 Matrix-Assisted Laser Desorption/Ionization (MALDI)
- •9.3.2.10.1 Principle of MALDI
- •9.3.2.10.2 Key Features of MALDI
- •9.3.2.10.3 Advantages of MALDI
- •9.3.2.10.4 Disadvantages of MALDI
- •9.3.2.10.5 Applications of MALDI
- •9.3.2.10.6 Mechanism of Ionization in MALDI
- •9.3.3 Mass Analyzer
- •9.3.3.1 Single Focusing Analyzer (FSA)
- •9.3.3.1.1 Components
- •9.3.3.1.2 Advantages:
- •9.3.3.1.3 Limitations
- •9.3.3.1.4 Applications:
- •9.3.3.2 Double Focusing Analyzer (DFA)
- •9.3.3.2.1 Components
- •9.3.3.2.2 Advantages
- •9.3.3.2.3 Limitations
- •9.3.3.2.4 Applications
- •9.3.3.3 Time-of-Flight (TOF) Analyzer
- •9.3.3.3.1 Components
- •9.3.3.3.2 Advantages
- •9.3.3.3.3 Limitations
- •9.3.3.3.4 Applications
- •9.3.3.3.5 Comparison Between MALDI and TOF mass spectrometry
- •9.3.3.4 Quadrupole Analyzer
- •9.3.3.4.1 Components
- •9.3.3.4.2 How it Works
- •9.3.3.4.3 Advantages
- •9.3.3.4.4 Limitations
- •9.3.3.4.5 Applications
- •9.3.3.5 Fourier-Transform Ion Cyclotron Resonance (FT-ICR) Analyzer
- •9.3.3.5.1 Components
- •9.3.3.5.2 How it Works
- •9.3.3.5.3 Advantages
- •9.3.3.5.4 Limitations
- •9.3.3.5.5 Applications
- •9.3.3.6 Ion Trap Analyzer
- •9.3.3.6.1 Types of Ion Traps
- •9.3.3.6.2 Components
- •9.3.3.6.3 How it Works
- •9.3.3.6.4 Advantages
- •9.3.3.6.5 Limitations
- •9.3.3.6.6 Applications
- •9.3.3.7 Magnetic Sector Analyzer
- •9.3.3.7.1 Components
- •9.3.3.7.2 How it Works
- •9.3.3.7.3 Advantages
- •9.3.3.7.4 Limitations
- •9.3.3.7.5 Applications
- •9.3.3.8 Orbitrap Analyzer
- •9.3.3.8.1 Components
- •9.3.3.8.2 How it Works
- •9.3.3.8.3 Advantages
- •9.3.3.8.4 Limitations
- •9.3.3.8.5 Applications
- •9.3.3.9 Hybrid Analyzers
- •9.3.3.9.1 Types of Hybrid Analyzers
- •9.3.3.9.2 Advantages
- •9.3.3.9.3 Limitations
- •9.3.3.9.4 Applications
- •9.3.4 Detector
- •9.3.4.1 TOF Detector
- •9.3.4.1.1 Operation Principle
- •9.3.4.1.2 Components
- •9.3.4.1.3 Types of TOF Detectors
- •9.3.4.1.4 Advantages
- •9.3.4.1.5 Applications
- •9.3.4.2 Electron Multiplier
- •9.3.4.2.1 Operation Principle
- •9.3.4.2.2 Components
- •9.3.4.2.3 Types of Electron Multipliers
- •9.3.4.2.4 Advantages
- •9.3.4.2.5 Applications
- •9.3.4.3 Microchannel Plate Detector
- •9.3.4.3.1 Operation Principle
- •9.3.4.3.2 Structure
- •9.3.4.3.3 Advantages
- •9.3.4.3.4 Types of MCP Detectors
- •9.3.4.3.5 Applications
- •9.3.4.4 Photomultiplier Tube
- •9.3.4.4.1 Operation Principle
- •9.3.4.4.2 Structure
- •9.3.4.4.3 Advantages
- •9.3.4.4.4 Types of PMTs
- •9.3.4.4.5 Applications
- •9.3.4.5 Ion Trap Detector
- •9.3.4.5.1 Operation Principle
- •9.3.4.5.2 Types of Ion Traps
- •9.3.4.5.3 Advantages
- •9.3.4.5.4 Applications
- •9.3.4.5.5 Limitations
- •9.3.4.6 Array Detectors
- •9.3.4.6.1 Operation Principle
- •9.3.4.6.2 Types of Array Detectors
- •9.3.4.6.3 Advantages
- •9.3.4.6.4 Applications
- •9.3.4.6.5 Limitations
- •9.3.4.7 Faraday Cup Detector
- •9.3.4.7.1 Operation Principle
- •9.3.4.7.2 Construction
- •9.3.4.7.3 Advantages
- •9.3.4.7.4 Applications
- •9.3.4.7.5 Limitations
- •9.3.4.8 Microelectromechanical Systems (MEMS) Detector
- •9.3.4.8.1 Operation Principle
- •9.3.4.8.2 Construction
- •9.3.4.8.3 Advantages
- •9.3.4.8.4 Applications
- •9.3.4.8.5 Limitations
- •9.3.4.9 Conversion Dynode Detector
- •9.3.4.9.1 Operation Principle
- •9.3.4.9.2 Construction
- •9.3.4.9.3 Advantages
- •9.3.4.9.4 Applications
- •9.3.4.9.5 Limitations
- •9.3.5 Data System
- •9.3.6 Vacuum System
- •9.3.7 Ion Separator
- •9.3.8 Collision Cells
- •9.3.9 High-Resolution Components
- •9.3.10 Data Visualization and Reporting Tools
- •9.4 MS Spectra
- •9.4.1 Mass Spectrum
- •9.4.1.1 Full Scan Spectrum
- •9.4.1.2 Selected Ion Monitoring
- •9.4.1.3 Product Ion Spectrum
- •9.4.1.4 Neutral Loss Spectrum
- •9.4.1.5 Selected Reaction Monitoring
- •9.4.2 Tandem Mass Spectrum
- •9.4.2.1 Product Ion Spectrum
- •9.4.2.2 Neutral Loss Spectrum
- •9.4.2.3 Selected Reaction Monitoring
- •9.4.2.4 Multiple Reaction Monitoring
- •9.4.2.5 All-Ion Fragmentation
- •9.4.3 High-Resolution Mass Spectrum
- •9.4.3.1 Key Features of HRMS
- •9.4.3.2 Types of High-Resolution Mass Spectra
- •9.4.4 Single-Ion Monitoring (SIM) Spectrum
- •9.4.4.1 Key Features of SIM Spectrum
- •9.4.4.2 Types of SIM Spectrum
- •9.5 Factors Affecting MS Spectra
- •9.5.1 Ionization Technique
- •9.5.2 Mass Analyzer Type
- •9.5.3 Sample Characteristics
- •9.5.4 Collision Energy
- •9.5.5 Mass Range and Resolution Settings
- •9.5.6 Experimental Conditions
- •9.5.7 Data Processing
- •9.5.8 Sample Preparation
- •9.6 Types of Peaks in Mass Spectra
- •9.6.1 Molecular Peak (M or [M]+)
- •9.6.2 Base Peak
- •9.6.3 Isotopic Peaks
- •9.6.4 Fragment Peaks (Fragments or [M-1]+)
- •9.6.5 Rearrangement Ion Peaks
- •9.6.6 Metastable Ion Peaks
- •9.6.7 Multicharged Ion Peaks
- •9.6.8 Negative Ion Peaks
- •9.7 Interpretation of Mass Spectra
- •9.7.1 Understanding Mass Spectra
- •9.7.2 Peak Identification
- •9.7.3 Fragmentation Patterns
- •9.7.4 Isotopic Patterns
- •9.7.5 Interpreting Mass Spectral Peaks
- •9.7.6 Peak Deconvolution and Data Analysis
- •9.7.7 Chemical Identification
- •9.7.8 Additional Data and Information
- •9.7.9 Consideration of Experimental Conditions
- •9.8 Mass Spectral Databases
- •9.8.1 Compound Identification
- •9.8.2 Structural Elucidation
- •9.8.3 Verification of Analytical Results
- •9.8.4 Types of Mass Spectral Databases
- •9.8.5 Searching and Comparing Mass Spectra
- •9.9 Peak Assignment in MS Spectra
- •9.9.1 Data Acquisition
- •9.10 Peak Detection
- •9.10.1 Peak Matching
- •9.10.2 Spectral Interpretation
- •9.10.3 Reference Spectra
- •9.10.4 Chemical Identification
- •9.10.5 Peak Labeling
- •9.10.6 Peak Integration and Quantification
- •9.11 Challenges in Peak Assignment
- •9.11.1 Complex Mixtures
- •9.11.2 Isobaric Compounds
- •9.11.3 Data Quality
- •9.11.4 Unknown Compounds
- •9.11.5 Interference
- •9.12 Factors Influencing Peaks in Mass Spectra
- •9.12.1 Ionization Technique
- •9.12.2 Sample Composition
- •9.12.3 Isotope Distribution
- •9.12.4 Ion Fragmentation
- •9.12.5 Resolution and Mass Range Settings
- •9.12.6 Experimental Conditions
- •9.12.7 Data Processing
- •9.12.8 Sample Preparation
- •9.12.9 Instrument Calibration
- •9.13 Hyphenated Techniques
- •9.13.1 Gas Chromatography-Mass Spectrometry (GC-MS)
- •9.13.2 Liquid Chromatography-Mass Spectrometry (LC-MS)
- •9.13.4 Capillary Electrophoresis-Mass Spectrometry (CE-MS)
- •9.13.5 Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
- •9.13.7 Solid-Phase Microextraction-Mass Spectrometry (SPME-MS)
- •9.13.8 Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS)
- •9.14 Applications
- •9.14.1 Drug Discovery and Development
- •9.14.2 Pharmacokinetics and Pharmacodynamics
- •9.14.3 Quality Control and Assurance Pharmaceuticals
- •9.14.4 Proteomics and Peptidomics
- •9.14.5 Metabolomics
- •9.14.6 Formulation Studies
- •9.14.7 Bioavailability and Bioequivalence Studies
- •9.14.8 Pharmaceutical Analysis
- •9.14.9 Pharmacogenomics
- •9.14.10 Drug Screening and Toxicology
- •9.14.11 Environmental Monitoring
- •9.14.12 Lipidomics
- •9.14.13 Clinical Diagnostics
- •9.14.14 Biomarker Discovery
- •9.14.15 Drug Analysis
- •9.14.16 Toxicology
- •9.14.17 Flavor Profiling
- •9.14.18 Molecular Identification
- •9.14.19 Structure Elucidation
- •9.14.20 Reaction Monitoring
- •9.14.21 Isotopic Analysis
- •9.14.22 Materials Science
- •9.14.23 Catalyst Analysis
- •9.14.24 Forensic Chemistry
- •9.14.25 Food Chemistry
- •9.14.26 Geochemistry
- •9.14.27 Nanomaterial Analysis
- •9.14.28 Environmental Monitoring
- •9.14.29 Air Quality Analysis
- •9.14.30 Water Quality Assessment
- •9.14.31 Soil Analysis
- •9.14.32 Waste Management
- •9.14.33 Biomonitoring
- •9.14.34 Pesticide Residue Analysis
- •9.14.35 Food Safety and Quality
- •9.14.36 Metabolomics Studies in Plants
- •9.14.37 Nutrient Analysis
- •9.14.38 Livestock Health
- •9.14.39 Biotechnology
- •9.14.40 Clinical Diagnostics
- •9.14.41 Biomarker Discovery
- •9.14.42 Infectious Disease Detection
- •9.14.43 Protein Quantification
- •9.14.44 Genomic and Proteomic Research
- •9.14.45 Clinical Research
- •9.14.46 Patient Stratification
- •9.14.47 Protein Structure and Function
- •9.15 Conclusion
- •9.16 Multiple Choice Questions
- •9.17 Short Questions
- •Suggested Reading
- •10. Comprehensive Insights into Nuclear Magnetic Resonance Spectroscopy
- •10.1 Introduction
- •10.2 Principle of NMR
- •10.2.1 Resonance
- •10.2.2 Spin
- •10.2.6 Nuclear Overhauser Enhancement
- •10.2.6.1 Mechanism of NOE
- •10.2.6.2 Types of NOE
- •10.2.6.3 Applications of NOE
- •10.2.6.4 NOE Experiments
- •10.2.6.5 Limitations of NOE
- •10.3 Nuclear Shielding
- •10.3.1 Mechanism of Nuclear Shielding
- •10.3.2 Factors Affecting Nuclear Shielding
- •10.3.3 Applications of Nuclear Shielding
- •10.3.4 Shielding and Deshielding Effects
- •10.4 Chemical Shielding
- •10.4.1 Mechanism of Chemical Shielding
- •10.4.2 Chemical Shifts and Shielding Constants
- •10.4.3 Factors Affecting Chemical Shielding
- •10.4.4 Applications of Chemical Shielding
- •10.5 Magnetic Shielding
- •10.5.1 Mechanism of Magnetic Shielding
- •10.5.2 Factors Affecting Magnetic Shielding
- •10.5.3 Applications of Magnetic Shielding
- •10.6 Anisotropic Shielding
- •10.6.1 Mechanism of Anisotropic Shielding
- •10.6.2 Chemical Shifts and Anisotropic Shielding
- •10.6.3 Applications of Anisotropic Shielding
- •10.6.4 Examples of Anisotropic Shielding
- •10.7 Isotropic Shielding
- •10.7.1 Mechanism of Isotropic Shielding
- •10.7.2 Chemical Shifts and Isotropic Shielding
- •10.7.3 Examples of Isotropic Shielding
- •10.7.4 Applications of Isotropic Shielding
- •10.8 Diamagnetic Shielding
- •10.8.1 Mechanism of Diamagnetic Shielding
- •10.8.2 Chemical Shifts and Diamagnetic Shielding
- •10.8.3 Examples of Diamagnetic Shielding
- •10.8.4 Applications of Diamagnetic Shielding
- •10.9 Paramagnetic Shielding
- •10.9.1 Mechanism of Paramagnetic Shielding
- •10.9.2 Chemical Shifts and Paramagnetic Shielding
- •10.9.3 Examples of Paramagnetic Shielding
- •10.9.4 Applications of Paramagnetic Shielding
- •10.9.5 Comparison with Other Shielding Types
- •10.10 Intensities of Resonance Signals
- •10.10.1 Factors Influencing Signal Intensities
- •10.10.1.1 Number of Nuclei
- •10.10.1.2 Relaxation Processes
- •10.10.1.3 Concentration of the Sample
- •10.10.1.4 Experimental Conditions
- •10.10.2 Integration of Signals
- •10.10.3 Applications of Signal Intensity Analysis
- •10.10.4 Types of Signal Intensities
- •10.10.4.1 1H NMR
- •10.10.4.1.1 Basic Principle
- •10.10.4.1.2 Chemical Shift Ranges
- •10.10.4.1.5 Applications of Proton NMR
- •10.10.4.1.6 Limitations
- •10.10.4.1.7 Example of Proton NMR Analysis
- •10.10.4.2.1 Basic Principle
- •10.10.4.2.2 Chemical Shift Ranges
- •10.10.4.2.3 Signal Multiplicity
- •10.10.4.2.4 Integration of Signals
- •10.10.4.2.5 Decoupling Techniques
- •10.10.4.2.7 Limitations
- •10.10.4.2.8 Example of Carbon-13 NMR Analysis
- •10.11 Types of NMR Spectroscopy
- •10.11.1 1D NMR Spectroscopy
- •10.11.1.1 Basic Principles of 1D NMR
- •10.11.1.2 Types of Nuclei Analyzed in 1D NMR
- •10.11.1.3 Key Features of 1D NMR Spectroscopy
- •10.11.1.3.1 Chemical Shift
- •10.11.1.3.3 Integration
- •10.11.1.4 Common Experiments in 1D NMR
- •10.11.1.5 Applications of 1D NMR
- •10.11.1.6 Limitations of 1D NMR
- •10.11.1.7 Example of 1D NMR Analysis
- •10.11.2 2D NMR Spectroscopy
- •10.11.2.1 Principle of 2D NMR
- •10.11.2.2 Types of 2D NMR Spectroscopy
- •10.11.2.2.1 COSY
- •10.11.2.2.2 Heteronuclear Single Quantum Coherence (HSQC)
- •10.11.2.2.3 Heteronuclear Multiple Bond Correlation (HMBC)
- •10.11.2.2.4 Nuclear Overhauser Effect Spectroscopy (NOESY)
- •10.11.2.2.5 Total Correlation Spectroscopy (TOCSY)
- •10.11.2.3 Key Features of 2D NMR
- •10.11.2.4 Applications of 2D NMR
- •10.11.2.5 Advantages of 2D NMR
- •10.11.2.6 Limitations of 2D NMR
- •10.11.2.7 Example of 2D NMR Analysis
- •10.11.3 3D and 4D NMR Spectroscopy
- •10.11.3.1 3D NMR Spectroscopy
- •10.11.3.1.1 Principle of 3D NMR
- •10.11.3.1.2 Key Techniques in 3D NMR
- •10.11.3.1.3 Applications of 3D NMR
- •10.11.3.2 4D NMR Spectroscopy
- •10.11.3.2.2 Key Techniques in 4D NMR
- •10.11.3.2.3 Applications of 4D NMR
- •10.11.3.3 Advantages of 3D and 4D NMR
- •10.11.3.4 Limitations of 3D and 4D NMR
- •10.11.3.5 Example of 3D and 4D NMR Applications in Protein Analysis
- •10.11.4 Solid-State NMR Spectroscopy
- •10.11.4.1 Principle of Solid-State NMR
- •10.11.4.2 Interactions in SSNMR
- •10.11.4.3 Applications of SSNMR
- •10.11.4.4 Techniques in SSNMR
- •10.11.4.5 Advantages of SSNMR
- •10.11.4.6 Limitations of SSNMR
- •10.11.5 High-Resolution NMR
- •10.11.5.1 Principle of HR-NMR
- •10.11.5.2 Key Features of HR-NMR
- •10.11.5.3 Types of HR-NMR
- •10.11.5.4 Applications of HR-NMR
- •10.11.5.5 Techniques Enhancing HR-NMR
- •10.11.5.6 Advantages of HR-NMR
- •10.11.5.7 Limitations of HR-NMR
- •10.11.6 Multinuclear NMR Spectroscopy
- •10.11.6.1 Principle of Multinuclear NMR Spectroscopy
- •10.11.6.2 Common Nuclei Studied in Multinuclear NMR
- •10.11.6.3 Features of Multinuclear NMR
- •10.11.6.4 Applications of Multinuclear NMR
- •10.11.6.5 Challenges in Multinuclear NMR
- •10.11.6.6 Advantages of Multinuclear NMR
- •10.11.7 Time-Domain NMR (TD-NMR)
- •10.11.7.1 Principle of TD-NMR
- •10.11.7.2 Features of TD-NMR
- •10.11.7.3 Applications of TD-NMR
- •10.11.7.4 Advantages of TD-NMR
- •10.11.7.5 Limitations of TD-NMR
- •10.11.8 In Vivo NMR Spectroscopy
- •10.11.8.1 Principle of In Vivo NMR Spectroscopy
- •10.11.8.2 Common Nuclei Studied in In Vivo NMR
- •10.11.8.3 Features of In Vivo NMR Spectroscopy
- •10.11.8.4 Applications of In Vivo NMR Spectroscopy
- •10.11.8.5 Advantages of In Vivo NMR Spectroscopy
- •10.11.8.6 Limitations of In Vivo NMR Spectroscopy
- •10.11.9 MRI
- •10.11.9.1 Principle of MRI
- •10.11.9.2 Types of MRI Scans
- •10.11.9.3 Applications of MRI
- •10.11.9.4 Advantages of MRI
- •10.11.9.5 Limitations of MRI
- •10.11.10 Diffusion NMR
- •10.11.10.1 Principle of Diffusion NMR
- •10.11.10.2 Steps in Diffusion NMR
- •10.11.10.3 Applications of Diffusion NMR
- •10.11.10.4 Diffusion Ordered Spectroscopy
- •10.11.10.5 Advantages of Diffusion NMR
- •10.11.10.6 Limitations of Diffusion NMR
- •10.12 Components of NMR Spectroscopy
- •10.12.1 The Magnet
- •10.12.2 RF Oscillator
- •10.12.3 Sample Holder
- •10.12.4 Radiofrequency Receiver
- •10.12.5 Pulse Programmer
- •10.12.6 Gradient Coils (Optional)
- •10.12.7 Computer and Data Processing Software
- •10.12.8 Shimming System
- •10.12.9 Sample Changer (Optional)
- •10.12.10 NMR Probes
- •10.13 Working of NMR
- •10.14 Sample Preparation for NMR Analysis
- •10.14.1 Choosing a Solvent
- •10.14.2 Sample Concentration
- •10.14.3 Sample Volume
- •10.14.4 Sample Purity
- •10.14.5 Degassing (Optional)
- •10.14.6 NMR Tubes
- •10.14.7 Internal Standards (Optional)
- •10.14.8 Solubility and Homogeneity
30 1 Comprehensive Insights into Pharmaceutical Analysis
• Primary standard solution: Prepared using a highly pure substance with a known
concentration. It is stable and does not degrade over time.
• Secondary standard solution: Standardized against a primary standard solution. It
is used when primary standards are unavailable or impractical.
1.8.6 Standard Solution
A solution with a precisely known concentration of a substance, used as a reference
in analytical techniques. There are two main types:
• Primary stand ard solution: A highly pure and stable solution with a precisely
known concentration, often used as a reference standard.
• Secondary standard solution: A solution prepared from a primary standard and
used for routine analytical work.
1.8.7 Molarity
A measure of concentration, expressed in moles of solute per liter of solution, often
used in volumetric analysis. Molarity is represented by M. It can be calculated by
using the following equation:
M = n=V
Where:
• M = Molarity (moles per liter)
• n = Number of moles of solute
• V = Volume of
Molarity tells us how concentrated a solution is in terms of the solute. For
example, a 1 M solution means that 1 mole of solute is dissolved in 1 L of solution.
This concept is essential in pharmaceutical analysis, where precise concentrations of
solutions are necessary for accurate measurements and reactions.
Example
ou d
If y
(M) of the solution would be:
issolve 0.5 moles of sodium chloride (NaCl) in 2 L of water, the molarity
the solution in
M = 0:5 moles=2 liters = 0:25 M
liters (L)
1.8 Terminologies Used in Pharmaceutical Analysis 31
1.8.8 Normality
Normality (N) is a measure of concentration that is defined as the number of
equivalents of solute per liter of solution. The formula for calculating normality is:
N = n
=V
eq
Where:
• N = Normality (equivalents per liter)
= Number of equivalents of solute
• n
eq
• V = Volume of the solution in liters (L)
The number of equivalents (n
n
= Mass of solute=Equivalent weight of solute
eq
) is calculated by:
eq
The equivalent weight depends on the reaction and can be determined by the
molecular weight divi ded by the valence (e.g., for acids, it is based on the number of
hydrogen ions (H
+
) it can donate or for bases, the hydroxide ions (OH-it can
accept).
Normality is particularly useful in titration reactions where the relationship
between reactants is based on equivalents, not just moles. For example, in acidbase react ions, normality allows us to calculate concentrations relative to the number
of protons (H
+
) an acid can donate or hydroxide ions (OH-) a base can accept.
Example
If you have 1 mole of sulfuric acid (H
+
), the normality for a 1 M solution of H₂SO₄ would be:
(H
N = M × number of H
), which has two ionizable hydrogen ions
₂SO₄
þ
= 1M × 2 = 2N
This means a 1 M solution of sulfuric acid is 2 N in terms of its ability to donate
hydrogen ions.
1.8.9 Indicators
Substances that change color in response to changes in pH (acid -base indicators) or
show other visible changes to signal the endpoint of a titration or analysis.
32 1 Comprehensive Insights into Pharmaceutical Analysis
1.8.10 Batch Analysis
The process of testing a specific batch of a pharmaceutical product to ensure it meets
the required quality and specification criteria before it is released to the market.
1.8.11 In Vitro Testing
Testing performed outside a living organism, often in a controlled laboratory
environment.
1.8.12 In Vivo Testing
Testing done within a living organism, such as animal studies or clinical trials to
assess a drug’s effects and safety.
1.8.13 pH
pH is a measure of the acidity or alkalinity of a solution. In pharmaceutical analysis,
pH is crucial in drug formulation, affecting the stability and solubility of drugs.
1.8.14 Titration
A quantitative chemical analysis method used to determine the concent ration of a
known analyte in a solution by adding a titrant with a known concentration until the
reaction is complete.
1.8.15 Limit of Detection
The smallest amount or concentration of analyte that can be reliably detected by an
analytical method, but not necessarily quantified as an exact value. Limit of detection (LOD) in pharmaceutical analys is is a critical parameter that quantifies the
smallest amount or concentration of an analyte that can be reliably detected but not
necessarily quantified using a specific analytical method. LOD is a fundamental
concept in analytical chemistry, especially in the pharmaceutical industry, where it is
essential for assessing the sensitivity and suitability of analytical methods for
detecting trace amounts of substances. It is calculated based on the signal-to-noise
ratio (S/N), typically using the following formula:
1.8 Terminologies Used in Pharmaceutical Analysis 33
LOD =
3:3 × δ
S
Where:
• σ = Standard deviation of the response (noise)
hod)
• S = Slope of the calibration curve (sensitivity of
the met
The LOD represents the minimum amount or concentration of an analyte in a
sample that produces a signal distinguishable from the background noise, but it is not
precise enough to be quantified. In practical terms, an analyte concentration at the
LOD can be detected as present, but its exact quantity cannot be accurately determined. The factor of 3.3 in the formula is derived from statistical considerations to
ensure the detection is reliable with a certain confidence level, often around 99%.
Example
If the stand ard deviation of a blank sample is 0.002 units and the slope of the
calibration curve for a particular analytical method is 0.1 units, the LOD would be
calculated as:
LOD =
This means that the smallest amoun
3:3 × 0:002
0:1
= 0:066 units
t of the analyte that can be detected using this
method is 0.066 units, though this amount cannot be precisely quantified.
1.8.16 Limit of Quantification
The limit of quantification (LOQ) in pharmaceutical analysis is a critical parameter
that defines the minimum concentration or amount of an analyte in a sample that can
be accurately and precisely quantified using a specific analytical method. LOQ is a
fundamental concept in analytical chemistry, particularly in the pharmaceutical
industry, where precise quantification of APIs, imp urities, and contaminants is
essential for product quality and regulatory compliance. The formula for LOQ is
generally expressed as:
10 × δ
S
Where:
• σ = Standard deviat
• S = Slope of the
calibration curve (sensitivity of the method)
LOQ =
ion of the response (noise)
34 1 Comprehensive Insights into Pharmaceutical Analysis
LOQ is the smallest concentration of an analyte that can be measured accurately
and precisely in a sample. The factor of 10 in the formula reflects the need for the
signal to be at least 10 times greater than the noise for reliable quantification. While
the LOD only identifies the presence of an analyte, LOQ allows for the exact
concentration to be determined with confidence. The LOQ is typically higher than
the LOD, as more stringent requirements are necessary for accurate measurement
rather than just detection.
Example
If the standard deviation of the response (noise) is 0.002 units and the slope of the
calibration curve is 0.1 units, the LOQ would be:
LOD =
10 × 0:002
This means that the analytical method can quantitatively measu
0:1
= 0:2 units
re the analyte
concentration when it reaches or exceeds 0.2 units, ensuring accuracy and precision
at this level.
1.8.17 Linearity
The ability of an analytical method to provide results directly proportional to the
concentration of the analyte within a given range. Linear relationships are often
depicted as a straight line in a calibration curve. Linearity in the context of analytical
chemistry refers to the relationship between the concentration or amount of an
analyte and the respon se (e.g., signal or instrument reading) obtained from an
analytical method. A linear relationship signifies that the method’s response is
directly proportional to changes in analyte concentration within a specified range.
Linearity is an essential attribute of many analytical methods, especially those used
for quantitative analysis. The general formula for linearity is expressed through the
equation of a straight line:
y = mx þ c
Where:
• y = Response (e.g., absorbance, peak area)
• x = Concentration
• m = Slope of the line
• c = Y-intercept (ideally
systematic errors)
of the analyte
(indicates the sensitivity of the method)
should be zero, but small deviations can occur due to
1.8 Terminologies Used in Pharmaceutical Analysis 35
Interpretation:
• Slope (m): Indicates how much the response (e.g., absorbance or signal intensity)
changes with a unit change in the concentration of the analyte. A steeper slope
means greater sensitivity.
• Intercept (c): Represents the response
zero. A significant intercept may indicate bias or background interference.
In a perfectly linear relationship, a plot of response y versus concentration
x should yield a straight line, validating the method’s ability to quantify the analyte
across the specified range.
when the concent
ration of the analyte is
1.8.18 Sensitivity
Sensitivity in pharmaceutical analysis refers to the ability of an analytical method to
detect and respond to changes in the concentration or amount of an analyte in a
sample. It measures how well the method can distinguish small variations in analyte
levels, making it a critical parameter for assessing the method’s capability to
quantify analytes accurately, especially at low concentrations. Sensitivity is essential
in pharmaceutical analysis, as it influences the method’s ability to detect trace
impurities, contaminants, or APIs in pharmaceutical products
1.8.19 Precision
Precision in pharmaceutical analysis refers to the ability of an analytical method to
produce consistent and reproducible results when the same sample is analyzed
repeatedly under the same conditions. It assesses the degree of scatter or variability
in the measurements obtained from the method. Precision is a critical parameter in
analytical chemistry, particularly in pharmaceutical quality control, where it ensures
that the method can reliably produce consistent results, allowing for confident and
repeatable data analysis
1.8.20 Accuracy
Accuracy in pharmaceutical analysis refers to the degree of closeness between the
measured or determined value of an analyte in a sample and its true or reference
value. It is a fundamental parameter that assesses the reliability and correctness of an
analytical method’s results. Accuracy is a critical aspect of pharmaceutical analysis,
as it directly impacts the safety, efficacy, and quality of pharmaceutical products
36 1 Comprehensive Insights into Pharmaceutical Analysis
1.8.21 Selectivity
The ability of an analytical method to accurately distinguish and measure the target
analyte(s) in the presence of other components, including impurities, excipients, and
potential interferents in the sample matrix. Selectivity is a crucial parameter that
ensures the method’s specificity and its capability to provide reliable results in the
presence of various coexisting substances. It is particularly important in pharmaceutical analysis, where the purity, quality, and safety of pharmaceutical products must
be assessed with a high degree of confidence
1.8.22 Matrix
The components of a pharmaceutical formulation excluding the API. Analytical
methods must account for the matrix effect to avoid interference in the analysis.
1.8.23 Validation
The process of demonstrating that an analytical method is suitable for its intended
purpose, ensuring that it produces reliable, consistent, and accurate results.
1.8.24 Specificity
The ability of an analytical method to measure the analyte accurately and specifically
in the presence of components that may be expected to be present, such as impurities
or excipients.
1.8.25 Reproducibility
Reproducibility in pharmaceutical analysis, also known as inter-assay precision or
intermediate precision, refers to the ability of an analytical method to produce
consistent and reproducible results when the same sample is analyzed on different
occasions, typically under variations in conditions. It assesses the precision of the
method in terms of its ability to consistently generate results when the same sample
is analyzed by different operators, instrum ents, or laboratories. Reproducibility is a
critical parameter in analytical chemistry, especially in pharmaceutical quality control and research, where it ensures the reliability and consistency of analytical data
under different circumstances.
1.8 Terminologies Used in Pharmaceutical Analysis 37
1.8.26 Good Laboratory Practice
A system of guidelines that regulate the planning, conduct, monitoring, recording,
reporting, and archiving of laboratory studies, ensuring reliability and integrity of the
results.
1.8.27 Repeatability
Repeatability in pharmaceutical analysis, also known as intra-assay precision or
short-term precision, refers to the ability of an analytical method to produce consistent and reproducible results when the same sample is analyzed multiple times within
a short time frame and under the same conditions. It assesses the precision of the
method in terms of its ability to generate consistent results when a single sample is
analyzed repeatedly. Repeatability is a crucial parameter in analytical chemistry,
especially in pharmaceutical quality contr ol, where it ensures the reliability and
consistency of analytical data.
1.8.28 Dilution
Dilution in pharmaceutical analysis is a common laboratory technique used to reduce
the concentration of a sample or solution by adding a solvent, typically a diluent, to
achieve a desired concentration suitable for analysis. The process of dilution
involves mixing a known volume of the original sample (or a concentrated stock
solution) with a known volume of the diluent. The resulting solution, called the
“diluted solution,” is then thoroughly mixed to ensure homogeneity. The process of
dilution involves mixing a known volume of the original sample (or a concentrated
stock solution) with a known volume of the diluent. The resulting solution, called the
“diluted solution,” is then thoroughly mixed to ensure homogeneity. Pharmaceutical
analysts use precise measurements and calculations to perform dilutions accurately
and achieve the desired concentration for analysis. Dilution is a valuable technique
that helps ensure the accuracy and reliability of analytical results in pharmaceutical
quality control and research.
1.8.29 Range
The interval between the upper and lower concentration limits of an analyte in a
sample within which the analytical method has been demonstrated to have acceptable precision, accuracy, and linearity. There is not a specific mathematical formula
for the range, but it is often defined as:
38 1 Comprehensive Insights into Pharmaceutical Analysis
Range = C
max
- C
min
Where:
• C
= Maximum concentration of the analyte that the method can accurately and
max
precisely measure.
• C
= Minimum concentration of the analyte that the method can accurately and
min
precisely measure.
Interpretation:
• The range is critical in determining the method’s applicability to various
concentrations. It establishes the boundaries within whi ch the method is valid
and ensures accurate quantification of the analyte within that interval.
• The linearity, accuracy, and precision of the method are evaluated across the
range to confirm its reliability.
1.8.30 Pharmacopoeia
An official publication containing a list of pharmaceutical substances, their
properties, standards, and quality specifications. Examples include the United States
Pharmacopoeia and the European Pharmacopoeia.
1.8.31 Robustness
The ability of an analytical method to remain unaffe cted by small, deliberate
variations in method parameters and environmental conditions, providing consistent
results.
1.8.32 Active Pharmaceutical Ingredient
The biologically active component in a pharmaceutical product responsible for its
therapeutic effect.
1.8.33 Excipients
Inactive ingredients in pharmaceutical formulations that serve various purposes,
such as binders, fillers, and lubricants.
1.8 Terminologies Used in Pharmaceutical Analysis 39
1.8.34 Contaminant
A forei gn substance unintentionally introduced into a pharmaceutical product during
the manufacturing process. Analysis helps detect and remove such contaminants to
ensure product safety.
1.8.35 Assay
A quantitative or qualitative analysis performed to determine the content or concentration of an API in a pharmaceutical product. An assay helps confirm that the
product contains the correct amount of active ingredient.
1.8.36 Impurity
Any unwanted chemical substance present in a drug product, either from raw
materials, manufacturing processes, or degradation over time. Impurities are
identified and quantified through pharmaceutical analysis.
1.8.37 Stability Testing
Studies conducted to assess the stability and shelf life of pharmaceutical products
under various conditions.
1.8.38 Bioavailability
The rate and extent to which the active ingredient in a pharmaceutical product is
absorbed and becomes available at the site of action.
1.8.39 Quality Control
The processes and tests used to ensure that pharmaceutical products meet established
quality standards.
1.8.40 Chromatography
A technique used to separate, identify, and quantify components in a mixture. It
plays a key role in pharmaceutical analysis to ensure drug purity and consistency.
Соседние файлы в папке Библиотека им академика М.И. Перельмана